Michael Shea, MD
Cardiovascular Disease · Dover, DENPI 1659530178
Payments from drug & device makers
Across 399 payments — averaging $15.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$905
- Pfizer$850
- Amgen$712
- E.r. Squibb & Sons, L.L.C.$711
- AstraZeneca$477
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$454
- plus $2K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 79 | $905 |
| Pfizer | 48 | $850 |
| Amgen | 46 | $712 |
| E.r. Squibb & Sons, L.L.C. | 46 | $711 |
| AstraZeneca | 31 | $477 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 27 | $454 |
| Johnson & Johnson | 31 | $430 |
| Boehringer Ingelheim | 19 | $339 |
| Merck | 12 | $217 |
| Akcea Therapeutics, Inc. | 3 | $210 |
| Abbott | 11 | $194 |
| Boston Scientific | 3 | $77 |
| Bayer | 4 | $73 |
| Alnylam Pharmaceuticals Inc. | 3 | $66 |
| Medtronic(2 entities) | 3 | $58 |
| Esperion Therapeutics, Inc. | 3 | $56 |
| Regeneron Healthcare Solutions, Inc. | 3 | $52 |
| Novo Nordisk | 3 | $51 |
| Bridgebio Pharma, Inc. | 3 | $50 |
| Tactile Systems Technology Inc | 3 | $48 |
| Lundbeck LLC | 3 | $41 |
| Kowa Pharmaceuticals America, Inc. | 2 | $35 |
| Kestra Medical Technology Services, Inc. | 2 | $34 |
| Gilead | 1 | $31 |
| Bioventus LLC | 1 | $26 |
| Biotronik Inc. | 1 | $24 |
| Heartflow, Inc. | 1 | $21 |
| Irhythm Technologies, Inc. | 1 | $21 |
| BD | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Bardy Diagnostics, Inc. | 1 | $16 |
| Scpharmaceuticals Inc. | 1 | $14 |
| G Medical Diagnostic Services, Inc. | 1 | $13 |
| Daxor Corporation | 1 | $11 |
How this compares
$6,356 in reported general payments places this provider in the 65th percentile of 104 cardiovascular disease providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Dover
- Eranga HaththotuwaDover$15K
- Gurmeet SinghDover$9K
- John ShuckDover$3K
- Khaled EljazzarDover$3K
- Jennifer EakinDover$2K
- Anthony ClayNewark$2.3M
- William WeintraubNewark$1.3M
- Vinay HosmaneWilmington$256K
- Wasif QureshiBear$133K
- Sourin BanerjiNewark$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.